NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
KPI Green Energy Posts Over 68% Jump In Net Profit To ₹111.32 Crore For June Quarter
'OBCs, EBCs, Dalits To Get Tickets In Proportion To Their Population': Bihar Congress Chief
Two Men Jump Into Rushing River To Save Stranded Monkey In Jammu And Kashmir; Watch Video
Universal Account Number To Be Allotted Only Through Aadhaar-Based Face Authentication Technology: EPFO
